<DOC>
	<DOCNO>NCT01370512</DOCNO>
	<brief_summary>The hypothesis pyridostigmine improve safety factor ganglionic neural transmission , Droxidopa replete postganglionic neuron norepinephrine ( NE ) . This combination result enhance orthostatic release NE . The investigator already demonstrate pyridostigmine raise supine blood pressure .</brief_summary>
	<brief_title>Droxidopa / Pyridostigmine Orthostatic Hypotension</brief_title>
	<detailed_description />
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Hypotension , Orthostatic</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Pyridostigmine Bromide</mesh_term>
	<mesh_term>Droxidopa</mesh_term>
	<criteria>1 . The presence orthostatic hypotension ( fall systolic BP great equal 30 mm Hg ) require study ; 2 . Autonomic test clinical evaluation demonstrate OH neurogenic etiology .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>